The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

32Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The best validated susceptibility variants for Parkinson's disease are located in the α-synuclein (SNCA) and microtubule-associated protein tau (MAPT) genes. Recently, a protective p.N551K-R1398H-K1423K haplotype in the leucine-rich repeat kinase 2 (LRRK2) gene was identified, with p.R1398H appearing to be the most likely functional variant. To date, the consistency of the protective effect of LRRK2 p.R1398H across MAPT and SNCA variant genotypes has not been assessed. To address this, we examined 4 SNCA variants (rs181489, rs356219, rs11931074, and rs2583988), the MAPT H1-haplotype-defining variant rs1052553, and LRRK2 p.R1398H (rs7133914) in Caucasian (n= 10,322) and Asian (n= 2289) series. There was no evidence of an interaction of LRRK2 p.R1398H with MAPT or SNCA variants (all p ≥ 0.10); the protective effect of p.R1398H was observed at similar magnitude across MAPT and SNCA genotypes, and the risk effects of MAPT and SNCA variants were observed consistently for LRRK2 p.R1398H genotypes. Our results indicate that the association of LRRK2 p.R1398H with Parkinson's disease is independent of SNCA and MAPT variants, and vice versa, in Caucasian and Asian populations. © 2014 Elsevier Inc.

References Powered by Scopus

Meta-analysis in clinical trials

32920Citations
N/AReaders
Get full text

Quantifying heterogeneity in a meta-analysis

27112Citations
N/AReaders
Get full text

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases

9302Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role of monogenic genes in idiopathic Parkinson's disease

95Citations
N/AReaders
Get full text

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

91Citations
N/AReaders
Get full text

LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status

57Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Heckman, M. G., Elbaz, A., Soto-Ortolaza, A. I., Serie, D. J., Aasly, J. O., Annesi, G., … Ross, O. A. (2014). The protective effect of LRRK2 p.R1398H on risk of Parkinson’s disease is independent of MAPT and SNCA variants. Neurobiology of Aging, 35(1), 266.e5-266.e14. https://doi.org/10.1016/j.neurobiolaging.2013.07.013

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

37%

Researcher 17

33%

Professor / Associate Prof. 12

24%

Lecturer / Post doc 3

6%

Readers' Discipline

Tooltip

Neuroscience 16

30%

Medicine and Dentistry 14

26%

Agricultural and Biological Sciences 13

24%

Biochemistry, Genetics and Molecular Bi... 11

20%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 54

Save time finding and organizing research with Mendeley

Sign up for free